<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rai S</submitter><funding>Department of Health Research, India</funding><funding>Indian Council of Medical Research</funding><pagination>1174951</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10684698</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Parkinson's disease (PD) is an increasingly common neurodegenerative condition, which causes movement dysfunction and a broad range of non-motor symptoms. There is no molecular or biochemical diagnosis test for PD. The miRNAs are a class of small non-coding RNAs and are extensively studied owing to their altered expression in pathological states and facile harvesting and analysis techniques.&lt;h4>Methods&lt;/h4>A total of 48 samples (16 each of PD, aged-matched, and young controls) were recruited. The small extracellular vesicles (sEVs) were isolated and validated using Western blot, transmission electron microscope, and nanoparticle tracking analysis. Small RNA isolation, library preparation, and small RNA sequencing followed by differential expression and targeted predictio</pubmed_abstract><journal>Frontiers in neuroscience</journal><pubmed_title>Circulating plasma miR-23b-3p as a biomarker target for idiopathic Parkinson's disease: comparison with small extracellular vesicle miRNA.</pubmed_title><pmcid>PMC10684698</pmcid><funding_grant_id>2020-1194</funding_grant_id><funding_grant_id>R.11012/21/2021-GIA/HR</funding_grant_id><pubmed_authors>Bharti PS</pubmed_authors><pubmed_authors>Rani K</pubmed_authors><pubmed_authors>Reddy TJ</pubmed_authors><pubmed_authors>Inampudi KK</pubmed_authors><pubmed_authors>Pandey HC</pubmed_authors><pubmed_authors>Rani N</pubmed_authors><pubmed_authors>Kumar S</pubmed_authors><pubmed_authors>Rajan R</pubmed_authors><pubmed_authors>Sharma V</pubmed_authors><pubmed_authors>Modi GP</pubmed_authors><pubmed_authors>Singh R</pubmed_authors><pubmed_authors>Yadav S</pubmed_authors><pubmed_authors>Rai S</pubmed_authors><pubmed_authors>Rastogi S</pubmed_authors><pubmed_authors>Verma BK</pubmed_authors><pubmed_authors>Nikolajeff F</pubmed_authors><pubmed_authors>Gorai PK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Circulating plasma miR-23b-3p as a biomarker target for idiopathic Parkinson's disease: comparison with small extracellular vesicle miRNA.</name><description>&lt;h4>Background&lt;/h4>Parkinson's disease (PD) is an increasingly common neurodegenerative condition, which causes movement dysfunction and a broad range of non-motor symptoms. There is no molecular or biochemical diagnosis test for PD. The miRNAs are a class of small non-coding RNAs and are extensively studied owing to their altered expression in pathological states and facile harvesting and analysis techniques.&lt;h4>Methods&lt;/h4>A total of 48 samples (16 each of PD, aged-matched, and young controls) were recruited. The small extracellular vesicles (sEVs) were isolated and validated using Western blot, transmission electron microscope, and nanoparticle tracking analysis. Small RNA isolation, library preparation, and small RNA sequencing followed by differential expression and targeted predictio</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2026-06-03T12:24:34.103Z</modification><creation>2025-04-06T09:39:29.801Z</creation></dates><accession>S-EPMC10684698</accession><cross_references><pubmed>38033547</pubmed><doi>10.3389/fnins.2023.1174951</doi></cross_references></HashMap>